Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Dentsply Sirona (XRAY) Capital Expenditures (2016 - 2025)

Dentsply Sirona's Capital Expenditures history spans 17 years, with the latest figure at $41.0 million for Q4 2025.

For the quarter ending Q4 2025, Capital Expenditures fell 19.61% year-over-year to $41.0 million, compared with a TTM value of $131.0 million through Dec 2025, down 27.22%, and an annual FY2025 reading of $131.0 million, down 27.22% over the prior year.
Capital Expenditures for Q4 2025 was $41.0 million at Dentsply Sirona, up from $39.0 million in the prior quarter.
The five-year high for Capital Expenditures was $100.0 million in Q3 2024, with the low at $5.0 million in Q2 2024.
Average Capital Expenditures over 5 years is $37.6 million, with a median of $36.5 million recorded in 2021.
Year-over-year, Capital Expenditures crashed 84.85% in 2024 and then soared 480.0% in 2025.
Tracing XRAY's Capital Expenditures over 5 years: stood at $41.0 million in 2021, then fell by 21.95% to $32.0 million in 2022, then increased by 25.0% to $40.0 million in 2023, then increased by 27.5% to $51.0 million in 2024, then decreased by 19.61% to $41.0 million in 2025.
Per Business Quant, the three most recent readings for XRAY's Capital Expenditures are $41.0 million (Q4 2025), $39.0 million (Q3 2025), and $29.0 million (Q2 2025).